Eliot Sugarman

1.2k total citations
12 papers, 704 citations indexed

About

Eliot Sugarman is a scholar working on Molecular Biology, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Eliot Sugarman has authored 12 papers receiving a total of 704 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Surgery and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Eliot Sugarman's work include Cholesterol and Lipid Metabolism (4 papers), Lipoproteins and Cardiovascular Health (3 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers). Eliot Sugarman is often cited by papers focused on Cholesterol and Lipid Metabolism (4 papers), Lipoproteins and Cardiovascular Health (3 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers). Eliot Sugarman collaborates with scholars based in United States, United Kingdom and Vietnam. Eliot Sugarman's co-authors include Thomas Sand, Michael E. Perlman, John A. Williams, Patricia G. Cosgrove, M J Bamberger, Ronald W. Clark, Tamara A. Sutfin, Ronald T. Wester, Roger B. Ruggeri and Lee A. Morehouse and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Journal of Medicinal Chemistry.

In The Last Decade

Eliot Sugarman

12 papers receiving 680 citations

Peers

Countries citing papers authored by Eliot Sugarman

Since Specialization

Citations

This map shows the geographic impact of Eliot Sugarman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eliot Sugarman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eliot Sugarman more than expected).

Fields of papers citing papers by Eliot Sugarman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eliot Sugarman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eliot Sugarman. The network helps show where Eliot Sugarman may publish in the future.

Co-authorship network of co-authors of Eliot Sugarman

This figure shows the co-authorship network connecting the top 25 collaborators of Eliot Sugarman. A scholar is included among the top collaborators of Eliot Sugarman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eliot Sugarman. Eliot Sugarman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	Discovery of Anthranilic Acid Derivatives as Difluoromethylornithine Adjunct Agents That Inhibit Far Upstream Element Binding Protein 1 (FUBP1) Function 2022 ·Journal of Medicinal Chemistry ·(unknown), (unknown), Mukund P. Tantak, (unknown), (unknown), (unknown), (unknown), Paul Hershberger, Patrick Maloney, Satyamaheshwar Peddibhotla, Eliot Sugarman, Sally A. Litherland, J. Pablo Arnoletti, (unknown), David Levens, Otto Phanstiel	4
2	Discovery of small molecule antagonists of chemokine receptor CXCR6 that arrest tumor growth in SK-HEP-1 mouse xenografts as a model of hepatocellular carcinoma 2019 ·Bioorganic & Medicinal Chemistry Letters ·Satyamaheshwar Peddibhotla, Paul Hershberger, R. Jason Kirby, Eliot Sugarman, Patrick Maloney, E. Hampton Sessions, Daniela Divlianska, (unknown), (unknown), Anthony B. Pinkerton, Layton H. Smith, (unknown)	15
3	MondoA coordinately regulates skeletal myocyte lipid homeostasis and insulin signaling 2016 ·Journal of Clinical Investigation ·Byung Yong Ahn, Mangala M. Soundarapandian, (unknown), Satyamaheshwar Peddibhotla, Gregory P. Roth, Jian‐Liang Li, Eliot Sugarman, Ada Koo, Siobhan Malany, Miao Wang, Kyungmoo Yea, Jeanne K. Brooks, Teresa C. Leone, Xianlin Han, Rick B. Vega, Daniel P. Kelly	52
4	Discovery of Sulfonamidebenzamides as Selective Apoptotic CHOP Pathway Activators of the Unfolded Protein Response 2014 ·ACS Medicinal Chemistry Letters ·Daniel P. Flaherty, Justin Miller, Danielle M. Garshott, (unknown), (unknown), Yujie Li, Monika Milewski, Eliot Sugarman, Stefan Vasile, Sumeet Salaniwal, Ying Su, Layton H. Smith, Thomas D.Y. Chung, Anthony B. Pinkerton, Jeffrey Aubé, Michael U. Callaghan, Jennifer E. Golden, Andrew M. Fribley, Randal J. Kaufman	16
5	Identification of Inhibitors of Triacylglyceride Accumulation in Muscle Cells: Comparing HTS Results from 1536-Well Plate-Based and High-Content Platforms 2013 ·SLAS DISCOVERY ·Eliot Sugarman, Ada Koo, Eigo Suyama, Manuel E. Ruidíaz, Susanne Heynen‐Genel, (unknown), Stefan Vasile, Mangala M. Soundarapandian, Rick B. Vega, Daniel P. Kelly, Layton H. Smith, (unknown)	5
6	Discovery of PF-04620110, a Potent, Selective, and Orally Bioavailable Inhibitor of DGAT-1 2011 ·ACS Medicinal Chemistry Letters ·Robert L. Dow, Jiancheng Li, (unknown), E. Michael Gibbs, Jennifer L. LaPerle, John Litchfield, David W. Piotrowski, Michael J. Munchhof, (unknown), William J. Zavadoski, Gregory S. Walker, R. Kirk McPherson, (unknown), Eliot Sugarman, Angel Guzmán-Pérez, Paul DaSilva‐Jardine	70
7	Inhibition of CETP activity by torcetrapib reduces susceptibility to diet-induced atherosclerosis in New Zealand White rabbits 2007 ·Journal of Lipid Research ·Lee A. Morehouse, Eliot Sugarman, Patricia-Ann K. Bourassa, Thomas Sand, Francesca Zimetti, Feng Gao, George H. Rothblat, Anthony J. Milici	134
8	Cholesteryl Ester Transfer Protein Variants Have Differential Stability but Uniform Inhibition by Torcetrapib 2005 ·Journal of Biological Chemistry ·David B. Lloyd, Maruja E. Lira, Linda S. Wood, L. Kathryn Durham, Thomas B. Freeman, Gregory M. Preston, Xiayang Qiu, Eliot Sugarman, Peter C. Bonnette, Anthony J. Lanzetti, Patrice M. Milos, John F. Thompson	25
9	Dual-action hypoglycemic and hypocholesterolemic agents that inhibit glycogen phosphorylase and lanosterol demethylase 2004 ·Journal of Lipid Research ·H. James Harwood, Stephen F. Petras, Dennis J. Hoover, (unknown), (unknown), Eliot Sugarman, Bernard Hulin, Younggil Kwon, E. Michael Gibbs, (unknown), Judith L. Treadway	15
10	Raising High-Density Lipoprotein in Humans Through Inhibition of Cholesteryl Ester Transfer Protein 2004 ·Arteriosclerosis Thrombosis and Vascular Biology ·Ronald W. Clark, Tamara A. Sutfin, Roger B. Ruggeri, (unknown), Eliot Sugarman, (unknown), Patricia G. Cosgrove, Thomas Sand, Ronald T. Wester, John A. Williams, Michael E. Perlman, M J Bamberger	283
11	Comparison of synthetic saponin cholesterol absorption inhibitors in rabbits: evidence for a non-stoichiometric, intestinal mechanism of action 1999 ·Journal of Lipid Research ·Lee A. Morehouse, (unknown), Michael P. DeNinno, Philip B. Inskeep, Peter A. McCarthy, (unknown), (unknown), Eliot Sugarman, Robert W. Wilkins, (unknown), Heidi A. Woody, Lawrence M. Zaccaro, Charles E. Chandler	58
12	Steroidal Glycoside Cholesterol Absorption Inhibitors 1997 ·Journal of Medicinal Chemistry ·Michael P. DeNinno, Peter A. McCarthy, (unknown), (unknown), John B. Etienne, Michael P. Zawistoski, Faan Wen Bangerter, Charles E. Chandler, Lee A. Morehouse, Eliot Sugarman, Robert W. Wilkins, Heidi A. Woody, Lawrence M. Zaccaro	27

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact